Abstract P30: Therapeutic activation of pre-B-cell receptor signaling in high-risk pediatric ALL: exploiting TCF3 and MYC-linked vulnerabilities Jan 2024Published byBlood Cancer DiscoverySummaryconference-paper
Abstract P4-01-12: BAT8006, a novel FRα ADC with strong bystander effect, for the treatment of advanced solid tumor Jan 2023Published byCancer ResearchSummaryconference-paper
Abstract P4-01-32: BAT8008, a novel Trop-2 ADC with strong bystander effect, for the treatment of Trop-2 positive cancer Jan 2023Published byCancer ResearchSummaryconference-paper
Application of NOP14 gene and protein thereof as marker of sensitivity of tumor to mTOR inhibitor Jan 2022Summarypatent
SHROOM2 inhibits tumor metastasis through RhoA-ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma. Jan 2019Published byCell death & diseaseSummaryjournal-article
BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc. Jan 2018Published byCell death & diseaseSummaryjournal-article
Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation. Jan 2018Published byPLoS pathogensSummaryjournal-article
TNFRSF19 Inhibits TGFβ Signaling through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis. Jan 2018Published byCancer researchSummaryjournal-article
Induction of chemokine (C-C motif) ligand 5 by Epstein-Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma. Jan 2018Published byCancer scienceSummaryjournal-article
OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma. Jan 2018Published byTheranosticsSummaryjournal-article
A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis. Jan 2016Published byCancer lettersSummaryjournal-article